Pierre Fenaux

Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy:results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial

Claude Gardin, Pascal Turlure, Thierry Fagot et al. · Blood · 2007 · 171 citations · Full text

Medicine, Oncology, Pharmacology +13

Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome

Lionel Prin, Joël Plumas, Valérie Gruart et al. · Blood · 1991 · 52 citations · Full text

Life Sciences, Immunology, Pathology +9

American College of Rheumatology Guidance Statement for Diagnosis and Management of <scp>VEXAS</scp> Developed by the International <scp>VEXAS</scp> Working Group Expert Panel

A. Mékinian, Sophie Georgin‐Lavaille, Marcela A. Ferrada et al. · Arthritis & Rheumatology · 2025 · 26 citations · Full text

Medicine, Hematology, Internal Medicine +9

Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the <i>Groupe Francophone Des Myélodysplasies</i>

Lionel Adès, Thomas Prébet, Aspasia Stamatoullas et al. · Haematologica · 2016 · 24 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT

Carmelo Gurnari, Marie Robin, Lionel Adès et al. · Blood · 2025 · 18 citations

Medicine, Genetics, Hematology +17